<?xml version='1.0' encoding='UTF-8'?>
<uniprot>
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2014-10-29" version="176">
<accession>P15144</accession>
<accession>Q16728</accession>
<accession>Q6GT90</accession>
<accession>Q8IUK3</accession>
<accession>Q8IVH3</accession>
<accession>Q9UCE0</accession>
<name>AMPN_HUMAN</name>
<protein>
<recommendedName>
<fullName>Aminopeptidase N</fullName>
<shortName>AP-N</shortName>
<shortName>hAPN</shortName>
<ecNumber>3.4.11.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Alanyl aminopeptidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Aminopeptidase M</fullName>
<shortName>AP-M</shortName>
</alternativeName>
<alternativeName>
<fullName>Microsomal aminopeptidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Myeloid plasma membrane glycoprotein CD13</fullName>
</alternativeName>
<alternativeName>
<fullName>gp150</fullName>
</alternativeName>
<cdAntigenName>CD13</cdAntigenName>
</protein>
<gene>
<name type="primary">ANPEP</name>
<name type="synonym">APN</name>
<name type="synonym">CD13</name>
<name type="synonym">PEPN</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="FEBS Lett." volume="238" first="307" last="314">
<title>Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA.</title>
<authorList>
<person name="Olsen J."/>
<person name="Cowell G.M."/>
<person name="Koenigshoefer E."/>
<person name="Danielsen E.M."/>
<person name="Moeller J."/>
<person name="Laustsen L."/>
<person name="Hansen O.C."/>
<person name="Welinder K.G."/>
<person name="Engberg J."/>
<person name="Hunziker W."/>
<person name="Spiess M."/>
<person name="Sjoestroem H."/>
<person name="Noren O."/>
</authorList>
<dbReference type="PubMed" id="2901990"/>
<dbReference type="DOI" id="10.1016/0014-5793(88)80502-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS GLN-86 AND MET-603</scope>
<source>
<tissue>Intestine</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="J. Clin. Invest." volume="83" first="1299" last="1307">
<title>Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N.</title>
<authorList>
<person name="Look A.T."/>
<person name="Ashmun R.A."/>
<person name="Shapiro L.H."/>
<person name="Peiper S.C."/>
</authorList>
<dbReference type="PubMed" id="2564851"/>
<dbReference type="DOI" id="10.1172/JCI114015"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 2-21</scope>
<scope>VARIANT GLN-86</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="440" first="671" last="675">
<title>Analysis of the DNA sequence and duplication history of human chromosome 15.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Sharpe T."/>
<person name="Young S.K."/>
<person name="Rowen L."/>
<person name="O'Neill K."/>
<person name="Whittaker C.A."/>
<person name="Kamal M."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Kodira C.D."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Yang X."/>
<person name="Abbasi N."/>
<person name="Abouelleil A."/>
<person name="Arachchi H.M."/>
<person name="Baradarani L."/>
<person name="Birditt B."/>
<person name="Bloom S."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Burke J."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dorris L. III"/>
<person name="Dors M."/>
<person name="Eichler E.E."/>
<person name="Engels R."/>
<person name="Fahey J."/>
<person name="Fleetwood P."/>
<person name="Friedman C."/>
<person name="Gearin G."/>
<person name="Hall J.L."/>
<person name="Hensley G."/>
<person name="Johnson E."/>
<person name="Jones C."/>
<person name="Kamat A."/>
<person name="Kaur A."/>
<person name="Locke D.P."/>
<person name="Madan A."/>
<person name="Munson G."/>
<person name="Jaffe D.B."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Mauceli E."/>
<person name="Naylor J.W."/>
<person name="Nesbitt R."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Ratcliffe A."/>
<person name="Rounsley S."/>
<person name="She X."/>
<person name="Sneddon K.M.B."/>
<person name="Stewart S."/>
<person name="Sougnez C."/>
<person name="Stone S.M."/>
<person name="Topham K."/>
<person name="Vincent D."/>
<person name="Wang S."/>
<person name="Zimmer A.R."/>
<person name="Birren B.W."/>
<person name="Hood L."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16572171"/>
<dbReference type="DOI" id="10.1038/nature04601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="11999" last="12007">
<title>Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells.</title>
<authorList>
<person name="Shapiro L.H."/>
<person name="Ashmun R.A."/>
<person name="Roberts W.M."/>
<person name="Look A.T."/>
</authorList>
<dbReference type="PubMed" id="1675638"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-15</scope>
<source>
<tissue>Intestinal epithelium</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2002-01" db="EMBL/GenBank/DDBJ databases">
<title>Genomic organisation of aminopeptidase N.</title>
<authorList>
<person name="Eiz-Vesper B."/>
<person name="Fuchs N."/>
<person name="Gottschalk D."/>
<person name="Mueller K."/>
<person name="Reuter S."/>
<person name="Blasczyk R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-479 AND 524-967</scope>
<scope>VARIANT GLN-86</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="Biol. Chem. Hoppe-Seyler" volume="376" first="397" last="400">
<title>Identification of an alanine aminopeptidase in human maternal serum as a membrane-bound aminopeptidase N.</title>
<authorList>
<person name="Watanabe Y."/>
<person name="Iwaki-Egawa S."/>
<person name="Mizukoshi H."/>
<person name="Fujimoto Y."/>
</authorList>
<dbReference type="PubMed" id="7576235"/>
<dbReference type="DOI" id="10.1515/bchm3.1995.376.7.397"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-20 AND 70-81</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1993" name="FEBS Lett." volume="329" first="84" last="88">
<title>Cholesterol crystallization-promoting activity of aminopeptidase-N isolated from the vesicular carrier of biliary lipids.</title>
<authorList>
<person name="Nunez L."/>
<person name="Amigo L."/>
<person name="Rigotti A."/>
<person name="Puglielli L."/>
<person name="Mingrone G."/>
<person name="Greco A.V."/>
<person name="Nervi F."/>
</authorList>
<dbReference type="PubMed" id="8102610"/>
<dbReference type="DOI" id="10.1016/0014-5793(93)80199-5"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-18</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1984" name="Enzyme" volume="32" first="65" last="75">
<title>Purification and characterization of aminopeptidase N from human plasma.</title>
<authorList>
<person name="Tokioka-Terao M."/>
<person name="Hiwada K."/>
<person name="Kokubu T."/>
</authorList>
<dbReference type="PubMed" id="6149934"/>
</citation>
<scope>CHARACTERIZATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="4593" last="4597">
<title>Variable O-glycosylation of CD13 (aminopeptidase N).</title>
<authorList>
<person name="O'Connell P.J."/>
<person name="Gerkis V."/>
<person name="d'Apice A.J.F."/>
</authorList>
<dbReference type="PubMed" id="1705556"/>
</citation>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1992" name="Nature" volume="357" first="420" last="422">
<title>Human aminopeptidase N is a receptor for human coronavirus 229E.</title>
<authorList>
<person name="Yeager C.L."/>
<person name="Ashmun R.A."/>
<person name="Williams R.K."/>
<person name="Cardellichio C.B."/>
<person name="Shapiro L.H."/>
<person name="Look A.T."/>
<person name="Holmes K.V."/>
</authorList>
<dbReference type="PubMed" id="1350662"/>
<dbReference type="DOI" id="10.1038/357420a0"/>
</citation>
<scope>INTERACTION WITH HCOV-229E SPIKE GLYCOPROTEIN</scope>
<scope>CHARACTERIZATION OF HCOV-229E RECEPTOR FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1993" name="Exp. Hematol." volume="21" first="1695" last="1701">
<title>CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated.</title>
<authorList>
<person name="Favaloro E.J."/>
<person name="Browning T."/>
<person name="Facey D."/>
</authorList>
<dbReference type="PubMed" id="7902291"/>
</citation>
<scope>IDENTIFICATION OF SOLUBLE FORM</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1993" name="J. Virol." volume="67" first="6576" last="6585">
<title>CD13 (human aminopeptidase N) mediates human cytomegalovirus infection.</title>
<authorList>
<person name="Soderberg C."/>
<person name="Giugni T.D."/>
<person name="Zaia J.A."/>
<person name="Larsson S."/>
<person name="Wahlberg J.M."/>
<person name="Moller E."/>
</authorList>
<dbReference type="PubMed" id="8105105"/>
</citation>
<scope>CHARACTERIZATION OF CMV RECEPTOR FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="J. Gen. Virol." volume="77" first="2515" last="2521">
<title>Characterization of functional domains in the human coronavirus HCV 229E receptor.</title>
<authorList>
<person name="Kolb A.F."/>
<person name="Maile J."/>
<person name="Heister A."/>
<person name="Siddell S.G."/>
</authorList>
<dbReference type="PubMed" id="8887485"/>
</citation>
<scope>IDENTIFICATION OF RECEPTOR FUNCTIONAL DOMAINS FOR HCOV-229E INFECTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="Exp. Cell Res." volume="231" first="112" last="118">
<title>Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity.</title>
<authorList>
<person name="Noren K."/>
<person name="Hansen G.H."/>
<person name="Clausen H."/>
<person name="Noren O."/>
<person name="Sjostrom H."/>
<person name="Vogel L.K."/>
</authorList>
<dbReference type="PubMed" id="9056417"/>
<dbReference type="DOI" id="10.1006/excr.1996.3455"/>
</citation>
<scope>FUNCTION</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1997" name="J. Gen. Virol." volume="78" first="2795" last="2802">
<title>Identification of residues critical for the human coronavirus 229E receptor function of human aminopeptidase N.</title>
<authorList>
<person name="Kolb A.F."/>
<person name="Hegyi A."/>
<person name="Siddell S.G."/>
</authorList>
<dbReference type="PubMed" id="9367365"/>
</citation>
<scope>IDENTIFICATION OF RESIDUES CRITICAL FOR HCOV-229E INFECTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="J. Gen. Virol." volume="79" first="1387" last="1391">
<title>Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N.</title>
<authorList>
<person name="Hegyi A."/>
<person name="Kolb A.F."/>
</authorList>
<dbReference type="PubMed" id="9634079"/>
</citation>
<scope>IDENTIFICATION OF RECEPTOR FUNCTIONAL DOMAINS FOR TGEV INFECTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="J. Immunol." volume="164" first="129" last="135">
<title>Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells.</title>
<authorList>
<person name="Dong X."/>
<person name="An B."/>
<person name="Salvucci Kierstead L."/>
<person name="Storkus W.J."/>
<person name="Amoscato A.A."/>
<person name="Salter R.D."/>
</authorList>
<dbReference type="PubMed" id="10605003"/>
<dbReference type="DOI" id="10.4049/jimmunol.164.1.129"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYMATIC CLEAVAGE OF ANTIGEN PEPTIDES BOUND TO CLASS II MHC</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Cancer Res." volume="60" first="722" last="727">
<title>Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.</title>
<authorList>
<person name="Pasqualini R."/>
<person name="Koivunen E."/>
<person name="Kain R."/>
<person name="Lahdenranta J."/>
<person name="Sakamoto M."/>
<person name="Stryhn A."/>
<person name="Ashmun R.A."/>
<person name="Shapiro L.H."/>
<person name="Arap W."/>
<person name="Ruoslahti E."/>
</authorList>
<dbReference type="PubMed" id="10676659"/>
</citation>
<scope>ROLE IN ANGIOGENESIS</scope>
<scope>CHARACTERIZATION OF RECEPTOR FOR TUMOR-HOMING PEPTIDES FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Fertil. Steril." volume="75" first="1172" last="1176">
<title>Expression of aminopeptidase N in human endometrium and regulation of its activity by estrogen.</title>
<authorList>
<person name="Seli E."/>
<person name="Senturk L.M."/>
<person name="Bahtiyar O.M."/>
<person name="Kayisli U.A."/>
<person name="Arici A."/>
</authorList>
<dbReference type="PubMed" id="11384645"/>
<dbReference type="DOI" id="10.1016/S0015-0282(01)01779-4"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY ESTRADIOL AND IL8</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="J. Virol." volume="75" first="9741" last="9752">
<title>Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.</title>
<authorList>
<person name="Wentworth D.E."/>
<person name="Holmes K.V."/>
</authorList>
<dbReference type="PubMed" id="11559807"/>
<dbReference type="DOI" id="10.1128/JVI.75.20.9741-9752.2001"/>
</citation>
<scope>MUTAGENESIS OF 288-ASP--SER-295 AND ASN-818</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Clin. Cancer Res." volume="8" first="3747" last="3754">
<title>Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.</title>
<authorList>
<person name="van Hensbergen Y."/>
<person name="Broxterman H.J."/>
<person name="Hanemaaijer R."/>
<person name="Jorna A.S."/>
<person name="van Lent N.A."/>
<person name="Verheul H.M."/>
<person name="Pinedo H.M."/>
<person name="Hoekman K."/>
</authorList>
<dbReference type="PubMed" id="12473585"/>
</citation>
<scope>FUNCTION OF SOLUBLE FORM</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Virol." volume="77" first="2530" last="2538">
<title>Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E.</title>
<authorList>
<person name="Bonavia A."/>
<person name="Zelus B.D."/>
<person name="Wentworth D.E."/>
<person name="Talbot P.J."/>
<person name="Holmes K.V."/>
</authorList>
<dbReference type="PubMed" id="12551991"/>
<dbReference type="DOI" id="10.1128/JVI.77.4.2530-2538.2003"/>
</citation>
<scope>INTERACTION WITH HCOV-229E SPIKE GLYCOPROTEIN</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Mol. Cell. Proteomics" volume="3" first="715" last="728">
<title>A proteomic analysis of human bile.</title>
<authorList>
<person name="Kristiansen T.Z."/>
<person name="Bunkenborg J."/>
<person name="Gronborg M."/>
<person name="Molina H."/>
<person name="Thuluvath P.J."/>
<person name="Argani P."/>
<person name="Goggins M.G."/>
<person name="Maitra A."/>
<person name="Pandey A."/>
</authorList>
<dbReference type="PubMed" id="15084671"/>
<dbReference type="DOI" id="10.1074/mcp.M400015-MCP200"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-265</scope>
<source>
<tissue>Bile</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-128; ASN-234; ASN-265; ASN-681 AND ASN-818</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-128; ASN-234; ASN-265; ASN-573; ASN-681 AND ASN-818</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="36804" last="36813">
<title>The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing.</title>
<authorList>
<person name="Wong A.H."/>
<person name="Zhou D."/>
<person name="Rini J.M."/>
</authorList>
<dbReference type="PubMed" id="22932899"/>
<dbReference type="DOI" id="10.1074/jbc.M112.398842"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 66-967 IN COMPLEX WITH ANGIOTENSIN-4 AND INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>SUBSTRATE-BINDING REGION</scope>
<scope>ZINC-BINDING SITES</scope>
<scope>ACTIVE SITE</scope>
<scope>GLYCOSYLATION AT ASN-128; ASN-234; ASN-265; ASN-319; ASN-527; ASN-625; ASN-681 AND ASN-818</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1998" name="Hum. Mutat. Suppl." volume="1" first="S158" last="S160">
<title>Identification of point mutations in the aminopeptidase N gene by SSCP analysis and sequencing.</title>
<authorList>
<person name="Lendeckel U."/>
<person name="Wex T."/>
<person name="Arndt M."/>
<person name="Frank K."/>
<person name="Franke A."/>
<person name="Ansorge S."/>
</authorList>
<dbReference type="PubMed" id="9452074"/>
</citation>
<scope>VARIANTS TYR-242 AND PRO-243</scope>
</reference>
<comment type="function">
<text evidence="4 5 6 8 21">Broad specificity aminopeptidase. Plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases. May play a critical role in the pathogenesis of cholesterol gallstone disease. May be involved in the metabolism of regulatory peptides of diverse cell types, responsible for the processing of peptide hormones, such as angiotensin III and IV, neuropeptides, and chemokines. Found to cleave antigen peptides bound to major histocompatibility complex class II molecules of presenting cells and to degrade neurotransmitters at synaptic junctions. Is also implicated as a regulator of IL-8 bioavailability in the endometrium, and therefore may contribute to the regulation of angiogenesis. Is used as a marker for acute myeloid leukemia and plays a role in tumor invasion. In case of human coronavirus 229E (HCoV-229E) infection, serves as receptor for HCoV-229E spike glycoprotein. Mediates as well human cytomegalovirus (HCMV) infection.</text>
</comment>
<comment type="catalytic activity">
<text evidence="15">Release of an N-terminal amino acid, Xaa-|-Yaa- from a peptide, amide or arylamide. Xaa is preferably Ala, but may be most amino acids including Pro (slow action). When a terminal hydrophobic residue is followed by a prolyl residue, the two may be released as an intact Xaa-Pro dipeptide.</text>
</comment>
<comment type="cofactor">
<text evidence="15">Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="subunit">
<text evidence="9 10 15 18">Homodimer. Interacts with the S1 domain of HCoV-229E spike protein.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="24">Cytoplasm</location>
<location evidence="24">Cytosol</location>
</subcellularLocation>
<text>A soluble form has also been detected.</text>
</comment>
<comment type="tissue specificity">
<text>Expressed in epithelial cells of the kidney, intestine, and respiratory tract; granulocytes, monocytes, fibroblasts, endothelial cells, cerebral pericytes at the blood-brain barrier, synaptic membranes of cells in the CNS. Also expressed in endometrial stromal cells, but not in the endometrial glandular cells. Found in the vasculature of tissues that undergo angiogenesis and in malignant gliomas and lymph node metastases from multiple tumor types but not in blood vessels of normal tissues. A soluble form has been found in plasma. It is found to be elevated in plasma and effusions of cancer patients.</text>
</comment>
<comment type="induction">
<text evidence="6">Estradiol and IL8/interleukin-8 decrease enzymatic activity in vitro in endometrial stromal cells by 40% and 30%, respectively.</text>
</comment>
<comment type="domain">
<text>Amino acids 260-353 are essential to mediate susceptibility to infection with HCoV-229E (in porcine/human chimeric studies) and more specifically amino acids 288-295 (mutagenesis studies).</text>
</comment>
<comment type="PTM">
<text evidence="1">Sulfated.</text>
</comment>
<comment type="PTM">
<text evidence="11 12 13 14 15 21">N- and O-glycosylated.</text>
</comment>
<comment type="PTM">
<text>May undergo proteolysis and give rise to a soluble form.</text>
</comment>
<comment type="miscellaneous">
<text>Found to serve as a receptor for tumor-homing peptides, more specifically NGR peptides. It could serve thus as a target for delivering drugs into tumors. Concentration in human hepatic bile, varies from 17.3 to 57.6 micrograms/ml.</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the peptidase M1 family.</text>
</comment>
<dbReference type="EC" id="3.4.11.2"/>
<dbReference type="EMBL" id="X13276">
<property type="protein sequence ID" value="CAA31640.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M22324">
<property type="protein sequence ID" value="AAA51719.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC018988">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC079075">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC058928">
<property type="protein sequence ID" value="AAH58928.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M55522">
<property type="protein sequence ID" value="AAA83399.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ421875">
<property type="protein sequence ID" value="CAD19098.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ421876">
<property type="protein sequence ID" value="CAD19098.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ426050">
<property type="protein sequence ID" value="CAD19802.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ427985">
<property type="protein sequence ID" value="CAD20931.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ427986">
<property type="protein sequence ID" value="CAD20931.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ427987">
<property type="protein sequence ID" value="CAD20931.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ427988">
<property type="protein sequence ID" value="CAD20931.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10356.1"/>
<dbReference type="PIR" id="A30325">
<property type="entry name" value="A30325"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001141.2">
<property type="nucleotide sequence ID" value="NM_001150.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005254949.1">
<property type="nucleotide sequence ID" value="XM_005254892.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.1239"/>
<dbReference type="PDB" id="4FYQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=66-967"/>
</dbReference>
<dbReference type="PDB" id="4FYR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A=66-967"/>
</dbReference>
<dbReference type="PDB" id="4FYS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=66-967"/>
</dbReference>
<dbReference type="PDB" id="4FYT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=66-967"/>
</dbReference>
<dbReference type="PDBsum" id="4FYQ"/>
<dbReference type="PDBsum" id="4FYR"/>
<dbReference type="PDBsum" id="4FYS"/>
<dbReference type="PDBsum" id="4FYT"/>
<dbReference type="ProteinModelPortal" id="P15144"/>
<dbReference type="SMR" id="P15144">
<property type="residue range" value="66-967"/>
</dbReference>
<dbReference type="BioGrid" id="106787">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="IntAct" id="P15144">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000300060"/>
<dbReference type="BindingDB" id="P15144"/>
<dbReference type="ChEMBL" id="CHEMBL1907"/>
<dbReference type="DrugBank" id="DB00973">
<property type="generic name" value="Ezetimibe"/>
</dbReference>
<dbReference type="DrugBank" id="DB06196">
<property type="generic name" value="Icatibant"/>
</dbReference>
<dbReference type="MEROPS" id="M01.001"/>
<dbReference type="PhosphoSite" id="P15144"/>
<dbReference type="DMDM" id="143811362"/>
<dbReference type="MaxQB" id="P15144"/>
<dbReference type="PaxDb" id="P15144"/>
<dbReference type="PRIDE" id="P15144"/>
<dbReference type="DNASU" id="290"/>
<dbReference type="Ensembl" id="ENST00000300060">
<property type="protein sequence ID" value="ENSP00000300060"/>
<property type="gene ID" value="ENSG00000166825"/>
</dbReference>
<dbReference type="GeneID" id="290"/>
<dbReference type="KEGG" id="hsa:290"/>
<dbReference type="UCSC" id="uc002bop.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="290"/>
<dbReference type="GeneCards" id="GC15M090328"/>
<dbReference type="H-InvDB" id="HIX0038141"/>
<dbReference type="HGNC" id="HGNC:500">
<property type="gene designation" value="ANPEP"/>
</dbReference>
<dbReference type="HPA" id="CAB002417"/>
<dbReference type="HPA" id="HPA004625"/>
<dbReference type="MIM" id="151530">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P15144"/>
<dbReference type="PharmGKB" id="PA24815"/>
<dbReference type="eggNOG" id="COG0308"/>
<dbReference type="GeneTree" id="ENSGT00760000119082"/>
<dbReference type="HOVERGEN" id="HBG006616"/>
<dbReference type="InParanoid" id="P15144"/>
<dbReference type="KO" id="K11140"/>
<dbReference type="OMA" id="WVLLNLN"/>
<dbReference type="OrthoDB" id="EOG754HNR"/>
<dbReference type="PhylomeDB" id="P15144"/>
<dbReference type="TreeFam" id="TF300395"/>
<dbReference type="BRENDA" id="3.4.11.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="REACT_147707">
<property type="pathway name" value="Metabolism of Angiotensinogen to Angiotensins"/>
</dbReference>
<dbReference type="SABIO-RK" id="P15144"/>
<dbReference type="GeneWiki" id="Alanine_aminopeptidase"/>
<dbReference type="GenomeRNAi" id="290"/>
<dbReference type="NextBio" id="1183"/>
<dbReference type="PRO" id="PR:P15144"/>
<dbReference type="Bgee" id="P15144"/>
<dbReference type="CleanEx" id="HS_ANPEP"/>
<dbReference type="ExpressionAtlas" id="P15144">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevestigator" id="P15144"/>
<dbReference type="GO" id="GO:0005793">
<property type="term" value="C:endoplasmic reticulum-Golgi intermediate compartment"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="IDA:UniProt"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular vesicular exosome"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005765">
<property type="term" value="C:lysosomal membrane"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004177">
<property type="term" value="F:aminopeptidase activity"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008237">
<property type="term" value="F:metallopeptidase activity"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004872">
<property type="term" value="F:receptor activity"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="IEA:InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002003">
<property type="term" value="P:angiotensin maturation"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR024571">
<property type="entry name" value="ERAP1-like_C_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001930">
<property type="entry name" value="Peptidase_M1"/>
</dbReference>
<dbReference type="InterPro" id="IPR014782">
<property type="entry name" value="Peptidase_M1_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11533">
<property type="entry name" value="PTHR11533"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11838">
<property type="entry name" value="ERAP1_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01433">
<property type="entry name" value="Peptidase_M1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00756">
<property type="entry name" value="ALADIPTASE"/>
</dbReference>
<dbReference type="PROSITE" id="PS00142">
<property type="entry name" value="ZINC_PROTEASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0031">Aminopeptidase</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0482">Metalloprotease</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0765">Sulfation</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="initiator methionine" description="Removed" evidence="16 19 20">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Aminopeptidase N" id="PRO_0000095081">
<location>
<begin position="2"/>
<end position="967"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic">
<location>
<begin position="2"/>
<end position="8"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="2">
<location>
<begin position="9"/>
<end position="32"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular">
<location>
<begin position="33"/>
<end position="967"/>
</location>
</feature>
<feature type="region of interest" description="Cytosolic Ser/Thr-rich junction">
<location>
<begin position="33"/>
<end position="68"/>
</location>
</feature>
<feature type="region of interest" description="Metalloprotease">
<location>
<begin position="69"/>
<end position="967"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HCoV-229E">
<location>
<begin position="260"/>
<end position="353"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="352"/>
<end position="356"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="3 15">
<location>
<position position="389"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic">
<location>
<position position="388"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic">
<location>
<position position="392"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic">
<location>
<position position="411"/>
</location>
</feature>
<feature type="site" description="Transition state stabilizer">
<location>
<position position="477"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="2">
<location>
<position position="176"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="2">
<location>
<position position="419"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="2">
<location>
<position position="424"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="2">
<location>
<position position="913"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="12 14 15">
<location>
<position position="128"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="12 14 15">
<location>
<position position="234"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="11 12 14 15">
<location>
<position position="265"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="15">
<location>
<position position="319"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="15">
<location>
<position position="527"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="14">
<location>
<position position="573"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="15">
<location>
<position position="625"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="12 14 15">
<location>
<position position="681"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)">
<location>
<position position="735"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="12 14 15">
<location>
<position position="818"/>
</location>
</feature>
<feature type="disulfide bond" evidence="15">
<location>
<begin position="761"/>
<end position="768"/>
</location>
</feature>
<feature type="disulfide bond" evidence="15">
<location>
<begin position="798"/>
<end position="834"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10152474." id="VAR_031262">
<original>V</original>
<variation>M</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs25653." id="VAR_014736" evidence="16 17 23">
<original>R</original>
<variation>Q</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_006727" evidence="22">
<original>D</original>
<variation>Y</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_006728" evidence="22">
<original>L</original>
<variation>P</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17240268." id="VAR_031263">
<original>A</original>
<variation>V</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8179199." id="VAR_031264">
<original>T</original>
<variation>M</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17240212." id="VAR_031265">
<original>I</original>
<variation>K</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8192297." id="VAR_031266" evidence="17">
<original>I</original>
<variation>M</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs25651." id="VAR_014737">
<original>S</original>
<variation>N</variation>
<location>
<position position="752"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in receptor activity and HCoV-229E infection." evidence="7">
<original>DYVEKQAS</original>
<variation>QSVEETAQ</variation>
<location>
<begin position="288"/>
<end position="295"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in receptor activity and HCoV-229E infection." evidence="7">
<original>DYVEKQAS</original>
<variation>QSVNEQAQ</variation>
<location>
<begin position="288"/>
<end position="295"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of receptor activity and blocks HCoV-229E infection. No loss of enzymatic activity." evidence="7">
<original>DYVEKQAS</original>
<variation>QSVNETAQ</variation>
<location>
<begin position="288"/>
<end position="295"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of receptor activity and blocks HCoV-229E infection. No loss of enzymatic activity.">
<original>EKQ</original>
<variation>NKT</variation>
<location>
<begin position="291"/>
<end position="293"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change of receptor activity and HCoV-229E infection.">
<original>E</original>
<variation>N</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change of receptor activity and HCoV-229E infection.">
<original>Q</original>
<variation>T</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="mutagenesis site" description="Very low receptor activity and HCoV-229E infection." evidence="7">
<original>N</original>
<variation>E</variation>
<location>
<position position="818"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA31640." ref="1" evidence="24">
<original>V</original>
<variation>E</variation>
<location>
<position position="536"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA31640." ref="1" evidence="24">
<original>L</original>
<variation>P</variation>
<location>
<position position="887"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="70"/>
<end position="72"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="73"/>
<end position="75"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="78"/>
<end position="91"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="102"/>
<end position="115"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="118"/>
<end position="123"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="135"/>
<end position="142"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="150"/>
<end position="156"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="157"/>
<end position="160"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="161"/>
<end position="168"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="175"/>
<end position="185"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="188"/>
<end position="200"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="203"/>
<end position="211"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="213"/>
<end position="216"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="231"/>
<end position="240"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="243"/>
<end position="249"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="256"/>
<end position="258"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="261"/>
<end position="269"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="282"/>
<end position="285"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="288"/>
<end position="293"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="299"/>
<end position="304"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="306"/>
<end position="310"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="311"/>
<end position="314"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="315"/>
<end position="331"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="338"/>
<end position="348"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="350"/>
<end position="354"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="359"/>
<end position="363"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="364"/>
<end position="367"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="371"/>
<end position="373"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="376"/>
<end position="394"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="396"/>
<end position="398"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="399"/>
<end position="403"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="404"/>
<end position="407"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="408"/>
<end position="425"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="427"/>
<end position="429"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="431"/>
<end position="434"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="435"/>
<end position="438"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="440"/>
<end position="447"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="459"/>
<end position="461"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="465"/>
<end position="470"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="474"/>
<end position="491"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="493"/>
<end position="507"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="510"/>
<end position="512"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="514"/>
<end position="527"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="536"/>
<end position="544"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="550"/>
<end position="555"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="556"/>
<end position="559"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="560"/>
<end position="565"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="579"/>
<end position="582"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="586"/>
<end position="588"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="590"/>
<end position="592"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="600"/>
<end position="602"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="604"/>
<end position="608"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="610"/>
<end position="612"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="620"/>
<end position="623"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="624"/>
<end position="626"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="631"/>
<end position="634"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="636"/>
<end position="649"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="650"/>
<end position="652"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="655"/>
<end position="670"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="676"/>
<end position="681"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="682"/>
<end position="688"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="692"/>
<end position="709"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="715"/>
<end position="736"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="737"/>
<end position="741"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="747"/>
<end position="762"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="766"/>
<end position="781"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="790"/>
<end position="792"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="793"/>
<end position="803"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="806"/>
<end position="817"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="822"/>
<end position="832"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="838"/>
<end position="848"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="851"/>
<end position="853"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="856"/>
<end position="858"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="859"/>
<end position="868"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="872"/>
<end position="882"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="884"/>
<end position="890"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="891"/>
<end position="894"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="898"/>
<end position="906"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="912"/>
<end position="924"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="925"/>
<end position="928"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="931"/>
<end position="933"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="934"/>
<end position="965"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10095"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10605003"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10676659"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11384645"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11559807"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12473585"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12551991"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1350662"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15084671"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1705556"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22932899"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2564851"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2901990"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6149934"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7576235"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8102610"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9056417"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9452074"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<sequence length="967" mass="109540" checksum="37B6BC1BF0D6B1F2" modified="2007-04-03" version="4">
MAKGFYISKSLGILGILLGVAAVCTIIALSVVYSQEKNKNANSSPVASTTPSASATTNPA
SATTLDQSKAWNRYRLPNTLKPDSYRVTLRPYLTPNDRGLYVFKGSSTVRFTCKEATDVI
IIHSKKLNYTLSQGHRVVLRGVGGSQPPDIDKTELVEPTEYLVVHLKGSLVKDSQYEMDS
EFEGELADDLAGFYRSEYMEGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHP
KDLTALSNMLPKGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLI
RIWARPSAIAAGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLV
TYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYL
GADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPASEINTPAQISELFDAISYSKG
ASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNRSIQLPTTVRDIM
NRWTLQMGFPVITVDTSTGTLSQEHFLLDPDSNVTRPSEFNYVWIVPITSIRDGRQQQDY
WLIDVRAQNDLFSTSGNEWVLLNLNVTGYYRVNYDEENWRKIQTQLQRDHSAIPVINRAQ
IINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAALSSLSYFKLMFDRSEVYGPMKN
YLKKQVTPLFIHFRNNTNNWREIPENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQWM
ENPNNNPIHPNLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWI
LNRYLSYTLNPDLIRKQDATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGSFSFSN
LIQAVTRRFSTEYELQQLEQFKKDNEETGFGSGTRALEQALEKTKANIKWVKENKEVVLQ
WFTENSK
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>